LT3977B - Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use - Google Patents

Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use Download PDF

Info

Publication number
LT3977B
LT3977B LTIP1713A LTIP1713A LT3977B LT 3977 B LT3977 B LT 3977B LT IP1713 A LTIP1713 A LT IP1713A LT IP1713 A LTIP1713 A LT IP1713A LT 3977 B LT3977 B LT 3977B
Authority
LT
Lithuania
Prior art keywords
methyl
compound
benzimidazole
pyridinyl
mmol
Prior art date
Application number
LTIP1713A
Other languages
English (en)
Lithuanian (lt)
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1713A publication Critical patent/LTIP1713A/xx
Publication of LT3977B publication Critical patent/LT3977B/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
LTIP1713A 1990-06-20 1993-12-30 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use LT3977B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002206A SE9002206D0 (sv) 1990-06-20 1990-06-20 New compounds

Publications (2)

Publication Number Publication Date
LTIP1713A LTIP1713A (en) 1995-08-25
LT3977B true LT3977B (en) 1996-06-25

Family

ID=20379831

Family Applications (2)

Application Number Title Priority Date Filing Date
LTIP1713A LT3977B (en) 1990-06-20 1993-12-30 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
LTIP1712A LT3952B (en) 1990-06-20 1993-12-30 Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTIP1712A LT3952B (en) 1990-06-20 1993-12-30 Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Country Status (26)

Country Link
EP (1) EP0535081A1 (ja)
JP (1) JPH05507713A (ja)
CN (1) CN1058212A (ja)
AP (1) AP215A (ja)
AU (1) AU649453B2 (ja)
CA (1) CA2083714A1 (ja)
CZ (1) CZ279772B6 (ja)
FI (1) FI925766A (ja)
HU (1) HUT62881A (ja)
IE (1) IE912025A1 (ja)
IL (1) IL98470A0 (ja)
IS (1) IS3721A7 (ja)
LT (2) LT3977B (ja)
LV (1) LV10953A (ja)
MA (1) MA22199A1 (ja)
NO (1) NO924775D0 (ja)
NZ (1) NZ238546A (ja)
OA (1) OA09682A (ja)
PT (1) PT98035A (ja)
RO (1) RO110493B1 (ja)
SE (1) SE9002206D0 (ja)
TN (1) TNSN91049A1 (ja)
TW (1) TW216418B (ja)
WO (1) WO1991019711A1 (ja)
YU (1) YU104191A (ja)
ZA (2) ZA914297B (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
IS4232A (is) * 1993-12-06 1995-06-07 Astra Aktiebolag Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
AU5424500A (en) 2000-02-24 2001-09-03 Kopran Res Lab Ltd Orally administrable acid stable anti-ulcer benzimidazole derivatives
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
KR101061351B1 (ko) 2002-04-09 2011-08-31 플라멜 테크놀로지스 활성 성분 마이크로캡슐의 경구 현탁액
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
TW200606163A (en) 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
WO2007122686A1 (ja) * 2006-04-14 2007-11-01 Eisai R & D Management Co., Ltd. ベンズイミダゾール化合物
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
US20110009624A9 (en) * 2006-10-13 2011-01-13 Masato Ueda Benzimidazole compounds having gastric acid secretion inhibitory action
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
EA201290026A1 (ru) 2009-06-25 2012-07-30 Астразенека Аб Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
KR20240042153A (ko) * 2016-09-14 2024-04-01 위펑 제인 쳉 D-아미노산 옥시다제 (daao) 저해제로서 신규한 치환된 벤즈이미다졸 유도체

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1500043A (en) 1974-02-18 1978-02-08 Haessle Ab Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion
GB1525958A (en) 1974-05-16 1978-09-27 Haessle Ab 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
US4182766A (en) 1977-09-19 1980-01-08 Hoffmann-La Roche Inc. Naphth[2,3-d]imidazoles
US4255431A (en) 1978-04-14 1981-03-10 Aktiebolaget Hassle Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
BE898880A (fr) 1983-02-11 1984-08-10 Haessle Ab Nouveaux benzimidazoles, preparations pharmaceutiques qui les contiennent et leur preparation
EP0124495A2 (en) 1983-03-04 1984-11-07 Aktiebolaget Hässle Omeprazole salts
US4599347A (en) 1980-08-21 1986-07-08 Hoffmann-La Roche Inc. Tetrahydro-naphth (2.3-d) imidazole derivatives
EP0208452A2 (en) 1985-07-02 1987-01-14 Takeda Chemical Industries, Ltd. Pyridine derivatives, their production and use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
NZ234564A (en) 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
HU886738D0 (en) * 1987-10-30 1990-02-28 Haessle Ab Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles
JPH03501609A (ja) * 1987-12-11 1991-04-11 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規ベンゾイミダゾール誘導体
JPH03504497A (ja) * 1988-05-25 1991-10-03 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング 新規フルオルアルコキシ化合物

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1500043A (en) 1974-02-18 1978-02-08 Haessle Ab Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion
GB1525958A (en) 1974-05-16 1978-09-27 Haessle Ab 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
US4182766A (en) 1977-09-19 1980-01-08 Hoffmann-La Roche Inc. Naphth[2,3-d]imidazoles
US4255431A (en) 1978-04-14 1981-03-10 Aktiebolaget Hassle Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, pharmaceutical preparations containing same, and method for inhibiting gastric acid secretion
US4359465A (en) 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
US4599347A (en) 1980-08-21 1986-07-08 Hoffmann-La Roche Inc. Tetrahydro-naphth (2.3-d) imidazole derivatives
BE898880A (fr) 1983-02-11 1984-08-10 Haessle Ab Nouveaux benzimidazoles, preparations pharmaceutiques qui les contiennent et leur preparation
EP0124495A2 (en) 1983-03-04 1984-11-07 Aktiebolaget Hässle Omeprazole salts
EP0208452A2 (en) 1985-07-02 1987-01-14 Takeda Chemical Industries, Ltd. Pyridine derivatives, their production and use

Also Published As

Publication number Publication date
YU104191A (sh) 1994-01-20
LTIP1712A (en) 1995-08-25
MA22199A1 (fr) 1992-04-01
ZA914297B (en) 1992-03-25
EP0535081A1 (en) 1993-04-07
FI925766A0 (fi) 1992-12-18
IE912025A1 (en) 1992-01-01
LV10953A (lv) 1995-12-20
CA2083714A1 (en) 1991-12-21
SE9002206D0 (sv) 1990-06-20
IS3721A7 (is) 1991-12-21
CS189491A3 (en) 1992-04-15
CN1058212A (zh) 1992-01-29
CZ279772B6 (cs) 1995-06-14
ZA914296B (en) 1992-03-25
NO924775L (no) 1992-12-10
NO924775D0 (no) 1992-12-10
AP9100285A0 (en) 1991-07-31
AP215A (en) 1992-09-02
TNSN91049A1 (fr) 1992-10-25
RO110493B1 (ro) 1996-01-30
LT3952B (en) 1996-05-27
TW216418B (ja) 1993-11-21
LTIP1713A (en) 1995-08-25
AU649453B2 (en) 1994-05-26
HUT62881A (en) 1993-06-28
FI925766A (fi) 1992-12-18
JPH05507713A (ja) 1993-11-04
NZ238546A (en) 1994-03-25
HU9204033D0 (en) 1993-03-29
OA09682A (en) 1993-05-15
AU8009791A (en) 1992-01-07
WO1991019711A1 (en) 1991-12-26
IL98470A0 (en) 1992-07-15
PT98035A (pt) 1992-03-31

Similar Documents

Publication Publication Date Title
LT3977B (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0593463B1 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU634741B2 (en) Benzimidazole and (4-cyclopropyl methoxy pyridinyl) linked derivatives
JP2793907B2 (ja) 治療上活性な置換されたベンズイミダゾールおよびその製法
EP0173664A2 (en) Biologically active benzimidazole compounds and process for their preparation
US5025024A (en) Therapeutically active fluoro-substituted compound
AU3175293A (en) Substituted benzimidazoles, process for their preparation as well as their use

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19961230